Is Alnylam Pharmaceuticals a Buy?
Alnylam Pharmaceuticals (NASDAQ: ALNY) has been a phenomenal biotech stock. The company had its initial public offering in 2004. Shares are now 22 times more valuable than they were 16 years ago. That's an incredible stock performance. And yet the company is still not profitable.
Why is the stock market so in love with Alnylam? And is now a good time to buy shares?
Image source: Alnylam Pharmaceuticals.
Source Fool.com


